Medical advisory Board

kevinhughes.jpg

Kevin S. Hughes, MD, FACS is a co-founder and chief medical advisor to CRA Health LLC. Dr. Hughes is the Massachusetts General Hospital’s Surgical Director of the Breast Screening Program, Surgical Director of the Breast and Ovarian Cancer Genetics and Risk Assessment Program, and Co-Director of the Avon Comprehensive Breast Evaluation Center, and serves as the Medical Director of the Bermuda Cancer Genetics and Risk Assessment Clinic. He is an Associate Professor of Surgery at Harvard Medical School. Dr. Hughes is actively involved in the establishment of standards and in research regarding the genetics, screening, diagnosis, and treatment of breast cancer. He is the author of numerous papers and book chapters on the subjects of breast cancer, screening, diagnosis and treatment, and risk assessment.

David Euhus, MD, is a Professor of Surgery and Chief of Breast Surgery at the Johns Hopkins University School of Medicine in Baltimore, MD. He is the author of the popular cancer genetics software program, CancerGene, which has over 6000 users in more than 75 countries. He was on the faculty of the University of Texas Southwestern Medical Center at Dallas as an Assistant Professor of Surgery from 1996 to 2013. During his 17 years in Dallas he maintained a translational research laboratory focused on biological markers of breast cancer risk and developed one the nation’s largest Clinical Cancer Genetics programs. He completed his General and Oncologic Surgery training at UCLA in 1991 after which he served as a Surgical Oncologist in the US. Army.

Daniel B. Kopans, MD, FACR, is a Professor of Radiology at Harvard Medical School and founder of the Breast Imaging Division at the Massachusetts General Hospital. Dr. Kopans was among the first to recognize the value of Ultrasound, CT, and MRI in breast evaluation and developed the first "Breast Imaging" Division in the U.S. He pioneered innovations in early breast cancer detection, including tomosynthesis, a procedure that increases the accuracy of mammograms without significantly increasing radiation exposure, and the Kopans Wire, a tool that helps clinicians detect small breast tumors.

Giovanni Parmigiani, PhD, is Professor of Biostatistics at Harvard School of Public Health and chair of the Department of Biostatistics and Computational Biology at Dana-Farber Cancer Institute. He is an Associate Director for Population Sciences at the Dana-Farber/Harvard Cancer Center. His research interests include models and software for predicting who is at risk of carrying genetic variants that confer susceptibility to cancer. He is the inventor of BayesMendel, a risk prediction software for Mendelian diseases, and one of the primary developers of BRCAPRO, a model and software for genetic counseling of families at high risk of breast and ovarian cancer.